Next |
home / stock / rare / rare message board
Subject | By | Source | When |
---|---|---|---|
News; $RARE Ultragenyx Pharmaceutical Inc ($RARE) Q3 2020 | whytestocks | investorshub | 10/28/2020 11:15:29 AM |
Lets go !!! | Erz | investorshub | 06/02/2020 7:04:41 PM |
News: $RARE Ultragenyx Announces Sale of Future European | whytestocks | investorshub | 12/19/2019 2:00:42 AM |
News: $RARE Ultragenyx Expands Leadership Team and Promotes | whytestocks | investorshub | 06/17/2019 8:50:42 PM |
What does this Miss Primary end points mean | Scalp2Trade | investorshub | 10/26/2018 1:07:26 PM |
$RARE - FDA approves treatment for rare genetic | MinnieM | investorshub | 11/15/2017 6:18:44 PM |
https://seekingalpha.com/article/4101282-ultragenyx-short-opportunity | Inoviorulez | investorshub | 08/23/2017 9:36:37 PM |
Uh oh this may get ugly | Awl416 | investorshub | 08/22/2017 8:21:24 PM |
Congrats to those who got in! Still | pphm_mike | investorshub | 08/11/2016 4:48:54 PM |
Here's a more detailed bull case for $RARE | pphm_mike | investorshub | 08/05/2016 6:15:07 AM |
RARE - Top biotech stock for the money | pphm_mike | investorshub | 07/22/2016 2:52:00 PM |
$RARE recent news/filings | stocktrademan | investorshub | 12/06/2015 6:43:16 PM |
$RARE recent news/filings | stocktrademan | investorshub | 09/01/2015 4:13:26 PM |
$RARE recent news/filings | stocktrademan | investorshub | 07/10/2015 5:43:16 PM |
$RARE recent news/filings | stocktrademan | investorshub | 06/14/2015 2:17:58 AM |
$RARE Top performing IPO in 2014 | DITRLI | investorshub | 10/03/2014 2:13:19 PM |
$RARE Cowen Sees Ultragenyx Shares Outperforming Following Phase | maytepper | investorshub | 09/16/2014 2:45:06 PM |
Ultragenyx Pharmaceutical Inc. due diligence | stocktrademan | investorshub | 07/12/2014 4:00:54 PM |
Presentation is at 4:00 PM. Today. | SchlumpyStock-Picker | investorshub | 02/13/2014 7:05:28 PM |
Low Float with plenty of up side. | SchlumpyStock-Picker | investorshub | 02/03/2014 2:40:19 PM |
News, Short Squeeze, Breakout and More Instantly...
Ultragenyx Pharmaceutical Inc. Company Name:
RARE Stock Symbol:
NASDAQ Market:
Ultragenyx Pharmaceutical Inc. Website:
NOVATO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the develo...
NOVATO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, today announced that Eric Crombez, M.D., the company's c...
First quarter total revenue of $109 million, Crysvita® revenue of $83 million and Dojolvi® revenue of $16 million Reaffirmed 2024 expected total revenue guidance between $500 million to $530 million, Crysvita revenue of $375 million to $400 million, and Dojolvi revenue of $75 ...